Inflammation in the first days of life may leave a microbial fingerprint that persists into early infancy — and that fingerprint may matter more than previously recognized. The nearly routine dismissal of mild CRP elevations in healthy newborns as clinically insignificant is now complicated by evidence tying those elevations to measurable differences in early gut microbiota structure.
Drawing from the Finnish HELMi birth cohort, this prospective study measured plasma CRP in 105 full-term infants during the first four postnatal days, cross-referencing levels against perinatal records and 16S rRNA gene sequencing of stool samples collected at three weeks of age. A striking 57% of infants showed CRP at or above 3 mg/L despite no confirmed infection. Crucially, most traditional clinical explanations — maternal Group B Streptococcus colonization, intrapartum antibiotic use, delivery mode, or early neonatal complications — did not account for these elevations, with the narrow exception of higher day-three CRP following spontaneous versus induced vaginal delivery. Infants with elevated CRP showed reduced prevalence of the bacterial family Acidaminococcaceae in gut microbiota at three weeks, while birth mode, antibiotic exposure, and umbilical artery pH in the asphyxia range each independently shaped distinct microbial profiles.
Acidaminococcaceae, a family within Firmicutes, includes short-chain fatty acid–producing genera such as Acidaminococcus, which have been implicated in early immune education and intestinal barrier maturation. Their reduced presence during a period of subclinical inflammation raises mechanistic questions worth pursuing: does perinatal inflammatory signaling suppress colonization of these organisms, or do their absence and the CRP elevation share a common upstream driver? The study's 105-infant sample limits statistical power, and the cross-sectional microbiota snapshot at three weeks cannot establish causality or reveal whether these early compositional differences persist. Nonetheless, as an incremental but genuinely thought-provoking contribution, this work reinforces the view that neonatal inflammatory events — even subclinical ones — are biologically consequential for early microbiome assembly.